Loading publications…
The last 5 uploaded publications
Lysosomal membrane permeabilization enhances the anticancer effects of RNA Polymerase I transcription inhibitors
Lucille Ferret, Jonathan Pol, Allan Sauvat, Gautier Stoll, Karla Alvarez-Valadez, Alexandra Müller, Julie Le Naour, F. Peyre, Gerasimos Anagnostopoulos, Isabel Martins, Maria Chiara Maiuri, Harald Wodrich, Lionel Guittat, Jean‐Louis Mergny, Guido Guido Kroemer, Mojgan Djavaheri‐Mergny (2025). Lysosomal membrane permeabilization enhances the anticancer effects of RNA Polymerase I transcription inhibitors. , DOI: https://doi.org/10.1101/2025.03.03.641132.
Preprint73 days agoLysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors
Lucille Ferret, Jonathan Pol, Allan Sauvat, Gautier Stoll, Karla Alvarez-Valadez, Alexandra Müller, Julie Le Naour, F. Peyre, Gerasimos Anagnostopoulos, Isabelle Martins, Maria Chiara Maiuri, Harald Wodrich, Lionel Guittat, Jean‐Louis Mergny, Guido Guido Kroemer, Mojgan Djavaheri‐Mergny (2025). Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors. , DOI: https://doi.org/10.1080/15548627.2025.2497614.
Article73 days agoTrial watch: Toll-like receptor ligands in cancer therapy
Julie Le Naour, Guido Guido Kroemer (2023). Trial watch: Toll-like receptor ligands in cancer therapy. , 12(1), DOI: https://doi.org/10.1080/2162402x.2023.2180237.
Article73 days agoRs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
Vincent Carbonnier, Julie Le Naour, Thomas Bachelot, Erika Vacchelli, Fabrice André, Suzette Delaloge, Guido Guido Kroemer (2023). Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer. , 12(1), DOI: https://doi.org/10.1080/2162402x.2023.2189823.
Article73 days agoAcyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance
Léa Montégut, Peng Liu, Liwei Zhao, María Pérez-Lanzón, Hui Chen, Misha Mao, Shuai Zhang, Lisa Derosa, Julie Le Naour, Flavia Lambertucci, Silvia Mingoia, Uxía Nogueira-Recalde, Rafael Mena‐Osuna, Irene Herranz-Montoya, Nabil Djouder, Sylvain Baulande, Hui Pan, Adrien Joseph, Meriem Messaoudene, Bertrand Routy, Marine Fidelle, T. Ben Ahmed, Olivier Caron, Pierre Busson, David Boulate, Mélanie Deschasaux, Nathalie Arnault, Jonathan Pol, Eliane Piaggio, Mathilde Touvier, Laurence Zitvogel, Suzette Delaloge, Isabelle Martins, Guido Guido Kroemer (2024). Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance. , 23(1), DOI: https://doi.org/10.1186/s12943-024-02098-5.
Article73 days ago